PPHF: Health Care Surveillance/Health Statistics - Surveillance Program Announcement: Behavioral Risk Factor Surveillance System Financed in Part by Prevention and Public Health Fund

 

The purpose of this program is to provide assistance to State and Territorial Health Departments to maintain and expand: 1) Specific health surveillance using telephone and multi-mode survey methodology for the behaviors of the general population that contribute to the occurrences and prevention of chronic diseases, injuries, and other public health threats; 2) The collection, analysis, and dissemination of BRFSS data to State and Territorial Health Department Categorical Programs for their use in assessing trends, directing program planning, evaluating program priorities, developing policy, and targeting relevant population groups. Specifically, this program will: A. Add questions specifically on health care access and use to the 2013 and 2014 Behavioral Risk Factor Surveillance System (BRFSS) questionnaires to measure the effect of ACA on the population; B. Increase the BRFSS landline sample size to restore the number of completed interviews achieved to 2011 levels. BRFSS programs should develop plans for increasing their sample size of their 2013 surveys which will increase the number of completed interviews achieved which will increase the precision of estimates in small areas and sub-populations; C. Increase the proportion of cell phone interviews completed on the 2013 BRFSS survey to maintain coverage and validity ? achieving at least a 25% completed interview rate by cell phone mode.

Deleted 03/27/2024 (Archived.) 93.745 Centers For Disease Control and Prevention, Department of Health and Human Services B - Project Grants Not applicable. Section 301 of the Public Health Service Act (as amended), Eligibility includes all 50 states, Washington D.C., Puerto Rico, the U.S. Virgin Islands, Guam, American Samoa, Palau, and the Federated States of Micronesia, who are currently funded through the Behavioral Risk Factor Surveillance System (BRFSS) Funding Opportunity Announcements (CDC-RFA-SO11-1101 and CDC-RFA-SO11-1102). Any U.S. State, political subdivision, and U.S. Territories as described above. Applicants should document a detailed work plan for meeting the objectives of the project, outline their method of operation, describe their evaluation procedures, and provide a budget with justification of funds requested. Applicants must comply with Administrative Requirements (ARs) outlined in 45 CFR Part 74 or Part 92 as appropriate. Preapplication coordination is not applicable. 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards applies to this program. Applicants must download the SF424 (R&R) application package associated with this supplemental funding opportunity from www.Grants.gov. If access to the internet is not available or if the applicant encounters difficulty accessing the forms on-line, contact the HHS/CDC Procurement and grants Office Technical Information Management Section (PGOTIMS) staff at (770) 477-2700 for further instructions. HHS/CDC Telecommunications for the hearing impaired or disabled is available at TTY 1-888-232-6348. If an applicant encounters technical difficulties with www.Grants.gov, the applicant should contact Grants.gov Customer Service. The Grants.gov Contact Center is available 24 hours a day, 7 days a week, with the exception of all Federal Holidays. The Contact Center provides customer service to the applicant community. The extended hours will provide applicants support around the clock, ensuring the best possible customer service is received any time it is needed. Applicants can reach the Grants.gov Support Center at 1-800-518-4726 or by e-mail at support@grants.gov. Submissions sent by e-mail, fax, CD's or thumb drives of applications will not be accepted. Eligible applications will be jointly reviewed for responsiveness by the National Center for Chronic Disease Prevention and Health Promotion and the CDC Procurement and Grants Office. Incomplete applications and applications that are non-responsive will not advance through the review process. Recipients will be notified in writing of the results. A technical review panel within the Population Health Surveillance Branch (PHSB), Division of Population Health (DPH), National Center for Chronic Disease Prevention and Health Promotion (NCCDPHP), CDC, will evaluate complete and responsive supplemental applications according to the published review criteria. Successful applicants will receive a Notice of Award (NoA) from the CDC Procurement and Grants Office. The NoA shall be only binding, authorizing document between the recipient and the CDC. The NoA will be signed by an authorized Grants Management Officer and e-mailed to the program director. A hard copy of the NoA will be mailed to the recipient fiscal officer identified in the application. Unsuccessful recipients will receive notification of the results of the application review by mail. Contact the headquarters or regional location, as appropriate for application deadlines 21-45 days after application submission deadline Not applicable. Renewals will be based on the conditions in the supplemental funding announcement and are subject to the availability of funds under Section 301 of the Public Health Service Act (as amended) and Section 4002 of the Patient Protection and Affordable Care Act, Public Law 111-148. Applications will be reviewed for completeness by the Procurement and Grants Office (PGO) staff and for responsiveness jointly by the National Center for Chronic Disease Prevention and Health Promotion and PGO. Incomplete applications and applications that are non-responsive to the eligibility criteria will not advance through the review process. Applicants will be notified if the application did not meet submission requirements. CDC will conduct a review to evaluate complete and responsive applications according to the criteria listed in Section V. Application Review Information within the supplemental funding opportunity announcement. Applicants will be notified if their application did not meet program requirements. Project funds may be used for costs associated with planning, implementing and data collecting surveillance information through the BRFSS for adding health care access and use questions to the 2013 BRFSS survey, and for implementing other program elements as described in Section 050 above and through CDC allowable and unallowable expenses. (Are there restrictions upon the use of the assistance? Ă— Yes □ Not Applicable. (If you select yes, you must describe the restrictions) Restrictions on Funding: • Section 503(a) – No part of any appropriation contained in this Act or transferred pursuant to section 4002 of Public Law 111-148 shall be used, other than for normal and recognized executive-legislative relationships, for publicity or propaganda purposes, for the preparation, distribution, or use of any kit, pamphlet, booklet, publication, electronic communication, radio, television, or video presentation designed to support or defeat the enactment of legislation before the Congress or any State or local legislature itself, or designed to support or defeat any proposed or pending regulation, administrative action, or order issued by the executive branch of any State or local government itself. • No part of any appropriate contained in this Act or transferred pursuant to section 4002 of Public Law 111-148 shall be used to pay the salary or expenses of any grant or contract recipient, or agent acting for such recipient, related to any grant or contract recipient, or agent acting for such recipient, related to any activity designed to influence the enactment of legislation, appropriations, regulation, administrative action, or Executive Order proposed or pending before the Congress or any State Government, State Legislature, or Local Legislative body, other than normal and recognized executive-legislative relationships or participation by an agency or officer of a State, local or tribal government in policymaking and administrative processes within the executive branch of that government. • The prohibitions in subsections (1) and (b) shall include any activity to advocate or promote any proposed,, pending, or future Federal, State, or local tax increase, or any proposed, pending, or future requirement or restriction on any legal consumer product, including its sale and marketing, including but not limited to the advocacy or promotion of gun control. • Sec. 218. None of the funds made available in this title may be used, in whole or in part, to advocate or promote gun control. • Sec. 253. Notwithstanding any other provision of this Act, no funds appropriated in this Act shall be used to carry out any program of distributing sterile needles or syringes for the hypodermic injection of illegal drugs. • Sec. 738. None of the funds made available by this Act may be used to enter into a contract, memorandum of understanding, or cooperative agreement with, make a grant to, or provide a loan or loan guarantee to any corporation that was convicted (or had an officer or agent of such corporation acting on behalf of the corporation convicted) of a felony criminal violation under any Federal or State law within the preceding 24 months, where the awarding agency is aware of the conviction, unless the agency has considered suspension or debarment of the corporation, or such officer or agent, and made a determination that this further action is not necessary to protect the interests of the Government. • Sec. 739. None of the funds made available by this Act may be used to enter into a contract, memorandum of understanding, or cooperative agreement with, make a grant to, or provide a loan or loan guarantee to, any corporation that any unpaid Federal tax liability that had been assessed, for which judicial and administrative remedies have been exhausted or have parsed, and that is not being paid in a timely manner pursuant to an agreement with the authority responsible for collecting the tax liability, where the awarding agency is aware of the unpaid tax liability, unless the agency has considered suspension of debarment of the corporation and made a determination that this further action is not necessary to protect the interests of the Government. • Section 433. None of the funds made available by this Act may be used to enter into a contract, memorandum of understanding, or cooperative agreement with, made a grant to, or provide a loan or loan guarantee to, any corporation that was convicted (or had an officer or agent of such corporation acting on behalf of the corporation convicted) of a felony criminal violation under any Federal law within the preceding 24 months, where the awarding agency is aware of the conviction, unless the agency has considered suspension or debarment of the corporation, or such officer or agent and made a determination that this further action is not necessary to protect the interests of the Government. • Section 434. None of the funds made available by this Act may be used to enter into a grant to, memorandum of understanding, or cooperative agreement with, make a grant to, or provide a loan or loan guarantee to, any corporation with respect to which any unpaid Federal tax liability that has been assessed for which all judicial and administrative remedies have been exhausted or have lapsed, and that is not being paid in a timely manner pursuant to an agreement with the authority responsible for collecting the tax liability, unless the agency has considered suspension or debarment of the corporation and made a determination that the suspension or debarment is not necessary to protect the interests of the Government. • Recipients may not use funds for research. • Recipients may not use funds for clinical care and pharmaceutical products. • Recipients may only expend funds for reasonable program purposes, including personnel, travel, supplies, and services, such as contractual. • Recipients may not generally use HHS/CDC/ATSDR funding for the purchase of furniture or equipment. Any such proposed spending must be identified in the budget. • Reimbursement of pre-award costs is not allowed Performance Reports: Federal Funding Accountability and Transparency Act of 2006 (FFATA): Public Law 109-282, the Federal Funding Accountability and Transparency Act of 2006 as amended (FFATA), requires full disclosure of all entities and organizations receiving Federal funds including grants, contracts, loans and other assistance and payments through a single publicly accessible web site, www.USASpending.gov. The Web site includes information on each Federal financial assistance award and contract over $25,000, including such information as: 1. The name of the entity receiving the award 2. The amount of the award 3. Information on the award including transaction type, funding agency, etc. 4. The location of the entity receiving the award 5. A unique identifier of the entity receiving the award; and 6. Names and compensation of highly-compensated officers (as applicable) Compliance with this law is primarily the responsibility of the Federal agency. However, two elements of the law require information to be collected and reported by recipients: 1) information on executive compensation when not already reported through the Central Contractor Registry; and 2) similar information on all sub-awards/subcontracts/consortiums over $25,000. For the full text of the requirements under the Federal Funding Accountability and Transparency Act of 2006, please view the following web site: http://frwebgate.access.gpo.gov/cgi-bin/getdoc.cgi?dbname=109_cong_bills&docid=f.s2590enr.txt.pdf. Not applicable. Records must follow the Records Management protocols. Statutory formula is not applicable to this assistance listing.

Matching requirements are not applicable to this assistance listing.

MOE requirements are not applicable to this assistance listing. Financial assistance is available for a 12-month budget period and a 22-month project period Funds will be awarded as a lump sum through a Notice of Award (NoA) from the agency Procurement and Grants Office. None/Not specified. Rosalyn Bell
4602 Buford Hwy
Mail Stop: F-78
Atlanta, GA 30341 US
aii9@cdc.gov
Phone: 7704884588 http://www.grants.gov 75-0943-0-1-551 (Cooperative Agreements) FY 18$0.00; FY 19 est $0.00; FY 20 est $0.00; FY 17$15,795,015.00; FY 16$4,000,000.00; - This number was to support PPHF monies for the BRFSS program. FY18 and FY19 did not utilize PPHF. Program is supported by another CFDA number. Future year funding is subject to availability of funds. Awards will range from approximately $50,000 through $125,000 with an average award of approximately $80,000 for FY12. Awards will range from approximately $50,000 through $100,000 with an average award of approximately $68,000 for FY13. Regulations governing this program are published under 45 Code of Federal Regulations (CFR) Part 74 or Part 92, as appropriate. For competing supplements, Administrative Regulations (ARs) remain in effect as published in the original funding announcement. For more information on the Code of Federal Regulations , see the National Archives and Records Administration at the following Internet address: http://www.access.gpo.gov/nara/cfr-table-search.html. Not applicable.